The delisting notice is the dominant event — Vivos has until Dec 2, 2026 to regain the $1.00 bid price, but also needs to cure the stockholders' equity deficiency. The equity raise (due June 15) is the binary catalyst: failure means the Streeterville exchange collapses and the company remains under heavy debt service. Monitor for the equity raise announcement; if it closes, the stock may rally on delisting relief, but the Streeterville preferred's 9% dividend and consent rights create a new overhang. If the raise fails, expect accelerated selling and potential Nasdaq delisting.
Price Chart
Executive Summary
Vivos Therapeutics disclosed a delisting notice from Nasdaq for failing to maintain a $1.00 minimum bid price, alongside a binding debt-to-equity exchange agreement with senior lender Streeterville Capital to convert up to $4.5M of debt into preferred and common stock, contingent on raising at least $2.6M in new equity by June 15, 2026. The company also issued a $5M convertible promissory note to an affiliate of New Seneca Partners to fund working capital ahead of a planned equity raise. The delisting risk and Nasdaq compliance deficiencies dominate the filing, making the overall picture bearish despite the debt restructuring efforts.
Key Facts
- Nasdaq notified Vivos on June 5, 2026 of non-compliance with the $1.00 minimum bid price rule (Rule 5550(a)(2)); 180-day cure period ends December 2, 2026.
- Company also not in compliance with Nasdaq's $2.4M minimum stockholders' equity requirement.
- Entered Exchange Agreement with Streeterville Capital to exchange up to $4.5M of secured debt for 2,500 Series A Preferred shares (stated value $1,050/share) and common shares worth $750,000, contingent on raising $2.6M in new equity by June 15, 2026.
- Streeterville agreed to a 90-day redemption standstill (until Sept 15, 2026) and a 60-day lock-up on securities sales (until Aug 15, 2026) if the exchange closes.
- Issued a $5M convertible promissory note to V-Co Investors 4 LLC (affiliate of New Seneca Partners) on May 7, 2026; initial $500K funded with 10% OID, total principal $550K.
- The V-Co 4 Note automatically converts dollar-for-dollar into equity of a planned $5.5M financing expected by June 30, 2026.
- Streeterville Note maturity extended to June 10, 2027, and monthly redemption cap reduced from $550K to $225K, contingent on the equity raise.
- Series A Preferred is non-convertible, non-voting, non-transferable, carries a 9% annual dividend (22% on default), and has liquidation preference over common stock.
- Streeterville gets consent rights over future debt/equity issuances above $2.5M and over fundamental transactions, asset sales, and AIM asset pledges.
Financial Impact
Up to $4.5M of secured debt converted to equity; $2.6M-$4.5M new equity raise required; $500K bridge loan already drawn with $550K principal (incl. OID). Delisting risk could wipe out equity value entirely.
Risk Factors
- Failure to raise $2.6M by June 15, 2026 voids the Streeterville exchange and leaves the company with full debt service and no equity cure for Nasdaq.
- Nasdaq delisting if bid price remains below $1.00 after Dec 2, 2026 or if stockholders' equity deficiency is not remedied.
- Streeterville's Series A Preferred gives it veto power over future financings above $2.5M, limiting strategic flexibility.
- V-Co 4 Note converts into equity of the planned raise, diluting existing common shareholders at potentially distressed prices.
- The company's $12M market cap makes any equity raise highly dilutive relative to current float.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-027641 |
| Exhibit: ex4-1.htm | 0001493152-26-027641 |
| Exhibit: ex99-1.htm | 0001493152-26-027641 |
| Document: form8-k.htm | 0001493152-26-027641 |
| Document: 0001493152-26-027641-index-headers.html | 0001493152-26-027641 |
| Document: 0001493152-26-027641-index.html | 0001493152-26-027641 |
| Document: 0001493152-26-027641.txt | 0001493152-26-027641 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | 8-K | $0.1347 | awaiting T+60 | — | $0.1280 (−4.97%) |
Oct 19, 2026 8d ago | Press Release | $0.1410 | awaiting T+60 | — | $0.1280 (−9.22%) |
Oct 19, 2026 8d ago | 8-K | $0.1406 | awaiting T+60 | — | $0.1280 (−8.96%) |
Oct 15, 2026 12d ago | 8-K | $0.1428 | awaiting T+60 | — | $0.1280 (−10.36%) |
Oct 15, 2026 12d ago | Press Release | $0.1428 | awaiting T+60 | — | $0.1280 (−10.36%) |
Sep 30, 2026 27d ago | 8-K | $0.1490 | awaiting T+60 | — | $0.1280 (+14.09%) |
Aug 28, 2026 8w ago | Press Release | $0.2249 | awaiting T+60 | — | $0.1280 (−43.09%) |
Aug 21, 2026 9w ago | 8-K | $0.2768 | awaiting T+60 | — | $0.1280 (−53.76%) |
Aug 14, 2026 10w ago | Press Release | $0.3012 | awaiting T+60 | — | $0.1280 (+57.50%) |
Aug 14, 2026 10w ago | Press Release | $0.3433 | awaiting T+60 | — | $0.1280 (−62.71%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers